Certified by Founder Lodge
HexemBio
United States - New York, NY
START UP
1 Disclosed Funding Rounds $10,400,000
0 Participating Investments
-
Founded date
2024
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
HexemBio is developing regenerative therapies based on the Synthetic Human Yolk Sac, a technology designed to rejuvenate aging blood stem cells by recreating the developmental environment whe
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 09 ,2026 | Seed | $10,400,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Neurosoft Bioelectronics | $7,500,000 | (May 22, 2026)
Century Health | $5,000,000 | (May 22, 2026)
CVRD Health | $5,000,000 | (May 22, 2026)
Oorja Bio | $30,000,000 | (May 22, 2026)
Findd.AI | $21,000,000 | (May 22, 2026)
